PRFX Q2 2024 Earnings Significant EPS Miss as Operating Losses Deepen SSBI Q1 2026 Earnings Modest EPS of 025 as Bank Navigates Stable Environment VELO Q1 2026 Earnings Strong EPS Beat Shocks Market Revenue Remains Undisclosed Cartesian Therapeutics Inc RNAC Q1 2026 Earnings ClinicalStage Biotech Reports WiderThanExpected Loss Stock Ticks Higher ERO Q1 2026 Earnings EPS Surges Past Estimates Even as Copper Prices Weigh VENU Q1 2026 Earnings EPS Misses Estimates as Revenue Figures Remain Undisclosed